Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma
- PMID: 28395901
- PMCID: PMC5521256
- DOI: 10.1016/j.jtcvs.2017.02.061
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma
Abstract
Objective: Soft-tissue sarcoma is a heterogeneous disease that frequently includes the development of pulmonary metastases. The purpose of this study is to determine factors associated with improved survival among patients with soft-tissue sarcoma to help guide selection for pulmonary metastasectomy.
Methods: We reviewed a prospectively maintained database and identified 803 patients who underwent pulmonary metastasectomy for metastatic soft-tissue sarcoma between September 1991 and June 2014; of these, 539 patients undergoing 760 therapeutic-intent pulmonary metastasectomies were included. Clinicopathologic variables and characteristics of treatment were examined. The outcomes of interest were overall survival and disease-free survival. Survival was estimated with the Kaplan-Meier method and compared between variables with the log-rank test. Factors associated with hazard of death and recurrence were identified via the use of univariable and multivariable Cox proportional hazards models.
Results: Median overall survival was 33.2 months (95% confidence interval, 29.9-37.1), and median disease-free survival was 6.8 months (95% confidence interval, 6.0-8.0). In multivariable analyses, leiomyosarcoma histologic subtype (P = .007), primary tumor size ≤10 cm (P = .006), increasing time from primary tumor resection to development of metastases (P < .001), solitary lung metastasis (P = .001), and minimally invasive resection (P = .023) were associated with lower hazard of death. Disease-free interval ≥1 year (P = .002), and 1 pulmonary metastasis (P < .001) were associated with lower hazard of disease recurrence.
Conclusions: In a large single-institution study, primary tumor histologic subtype and size, numbers of pulmonary metastases, disease-free interval, and selection for minimally invasive resection are associated with increased survival in patients undergoing pulmonary metastasectomy for soft-tissue sarcoma.
Keywords: lung cancer surgery; metastases; metastatic soft-tissue sarcoma; pulmonary metastasectomy; soft-tissue sarcoma.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Resection of pulmonary sarcomatous metastases: Cut to cure?J Thorac Cardiovasc Surg. 2017 Jul;154(1):331. doi: 10.1016/j.jtcvs.2017.03.011. Epub 2017 Mar 9. J Thorac Cardiovasc Surg. 2017. PMID: 28359577 No abstract available.
-
Discussion.J Thorac Cardiovasc Surg. 2017 Jul;154(1):329-330. doi: 10.1016/j.jtcvs.2017.02.062. Epub 2017 Apr 8. J Thorac Cardiovasc Surg. 2017. PMID: 28395902 No abstract available.
-
Evidence for resection of sarcoma pulmonary metastases: More, but better?J Thorac Cardiovasc Surg. 2017 Jul;154(1):317-318. doi: 10.1016/j.jtcvs.2017.03.132. Epub 2017 Apr 7. J Thorac Cardiovasc Surg. 2017. PMID: 28511805 No abstract available.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
-
- Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchere D, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. Cancer. 2001;91:1914–26. - PubMed
-
- Smith R, Demmy TL. Pulmonary metastasectomy for soft tissue sarcoma. Surg Oncol Clin N Am. 2012;21:269–86. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
